Tretinoin improves the anti-cancer response to cyclophosphamide, in a model-selective manner

Tretinoin improves the anti-cancer response to cyclophosphamide, in a model-selective manner

Abstract Background Chemotherapy is included in treatment regimens for many solid cancers, but when administered as a single agent it is rarely curative. The addition of immune checkpoint therapy to standard chemotherapy regimens has improved response rates and increased survival in some cancers. Ho...

Full description

Bibliographic Details
Main Authors: Caitlin M. Tilsed, M. Lizeth Orozco Morales, Rachael M. Zemek, Brianna A. Gordon, Matthew J. Piggott, Anna K. Nowak, Scott A. Fisher, Richard A. Lake, W. Joost Lesterhuis
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Cancer
Subjects:
Cyclophosphamide
Tretinoin
Interferon
Sensitisation
Combination treatment
Online Access:https://doi.org/10.1186/s12885-024-11915-5

Internet

https://doi.org/10.1186/s12885-024-11915-5

Similar Items